Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0IBYRY)
| ADC Name |
BCN-linker-Dxd4
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
BCN-linker-Dxd4
Click to Show/Hide
|
|||||
| Organization |
SYNAFFIX B.V.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
DX-8951 derivative (DXd)
|
Payload Info | ||||
| Payload Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
BCN-linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
BCN-linker-Dxd
|
|||||